Abbott (NYSE: ABT) announced today CE Marking (Conformite Europeenne) for a testosterone assay with improved sensitivity and clinical utility. With ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE